Henry Schein Inc. (NASDAQ:HSIC) – Equities researchers at William Blair increased their Q4 2016 earnings per share (EPS) estimates for Henry Schein in a report released on Monday. William Blair analyst J. Kreger now anticipates that the brokerage will earn $1.87 per share for the quarter, up from their previous estimate of $1.86.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Thursday, August 4th. The company reported $1.64 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.63 by $0.01. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The firm had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.85 billion. During the same period in the prior year, the firm earned $1.46 earnings per share. The business’s quarterly revenue was up 9.3% compared to the same quarter last year.

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

HSIC has been the subject of a number of other research reports. Zacks Investment Research cut Henry Schein from a “hold” rating to a “sell” rating in a research report on Tuesday, September 20th. Goldman Sachs Group Inc. upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price objective for the company in a research report on Tuesday. Robert W. Baird cut Henry Schein from an “outperform” rating to a “neutral” rating and lowered their price target for the company from $176.00 to $164.00 in a report on Friday. Finally, Bank of America Corp. began coverage on Henry Schein in a report on Monday, September 12th. They issued a “buy” rating and a $185.00 price target for the company. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Henry Schein has an average rating of “Hold” and an average price target of $159.50.

Shares of Henry Schein (NASDAQ:HSIC) opened at 156.05 on Thursday. Henry Schein has a 1-year low of $142.64 and a 1-year high of $183.00. The stock has a market capitalization of $12.76 billion, a price-to-earnings ratio of 26.44 and a beta of 1.05. The company’s 50 day moving average is $162.38 and its 200-day moving average is $170.17.

In related news, Director Paul Brons sold 3,381 shares of the business’s stock in a transaction that occurred on Monday, August 29th. The stock was sold at an average price of $164.03, for a total transaction of $554,585.43. Following the transaction, the director now directly owns 13,715 shares of the company’s stock, valued at approximately $2,249,671.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.27% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in HSIC. Quadrant Capital Group LLC raised its position in Henry Schein by 0.4% in the second quarter. Quadrant Capital Group LLC now owns 742 shares of the company’s stock valued at $128,000 after buying an additional 3 shares during the period. Montag & Caldwell LLC raised its position in Henry Schein by 0.3% in the second quarter. Montag & Caldwell LLC now owns 2,700 shares of the company’s stock valued at $477,000 after buying an additional 7 shares during the period. Cleararc Capital Inc. raised its position in Henry Schein by 0.9% in the second quarter. Cleararc Capital Inc. now owns 2,013 shares of the company’s stock valued at $356,000 after buying an additional 17 shares during the period. Wetherby Asset Management Inc. raised its position in Henry Schein by 0.6% in the second quarter. Wetherby Asset Management Inc. now owns 3,350 shares of the company’s stock valued at $592,000 after buying an additional 20 shares during the period. Finally, Ranger Investment Management L.P. raised its position in Henry Schein by 1.5% in the second quarter. Ranger Investment Management L.P. now owns 1,370 shares of the company’s stock valued at $242,000 after buying an additional 20 shares during the period. 91.98% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Company Profile

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

5 Day Chart for NASDAQ:HSIC

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.